PMC:4939752 / 42212-42478 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/4939752","sourcedb":"PMC","sourceid":"4939752","source_url":"https://www.ncbi.nlm.nih.gov/pmc/4939752","text":"Interleukin-4 Interleukin-4 (IL-4) has ability to increased CD20 promoter activity and CD20 expression but modestly improved rituximabactivity in RRCL and in primary B-cell lymphoma cells suggesting the existence of a defect in CD20 protein transport inRRCL. [106]","divisions":[{"label":"td","span":{"begin":0,"end":13}},{"label":"td","span":{"begin":15,"end":259}}],"tracks":[]}